Release Date: 30/03/17 17:19 Summary: OGC Material Summary & JORC Table 1 Price Sensitive: Yes Download Document 2.95MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling